Nexgel (NXGL) Operating Expenses (2018 - 2025)

Nexgel's Operating Expenses history runs 8 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• Quarterly Operating Expenses rose 6.16% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.9 million (up 26.04% YoY) and the FY2025 annual result came in at $7.9 million, up 24.74% from the prior year.
• Operating Expenses was $2.0 million for Q4 2025 at Nexgel, up from $2.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $2.0 million in Q4 2025 and bottomed at $478000.0 in Q1 2021.
• A 5-year average of $1.2 million and a median of $1.0 million in 2021 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses surged 114.29% — and 2023, when it declined 19.32%.
• Nexgel's Operating Expenses stood at $990000.0 in 2021, then declined by 17.47% to $817000.0 in 2022, then jumped by 38.56% to $1.1 million in 2023, then surged by 69.17% to $1.9 million in 2024, then climbed by 6.16% to $2.0 million in 2025.
• Business Quant data shows NXGL's Operating Expenses at $2.0 million in Q4 2025, $2.0 million in Q3 2025, and $1.9 million in Q2 2025.